Top compounds associated with response to CTD-2331H12.8


Feature Type Standardized
Nominal ANOVA
mRNA lovastatin CTRPv2 pan-cancer AAC -0.14 0.0002
mRNA SZ4TA2 CTRPv2 pan-cancer AAC 0.21 0.0003
mRNA SRT-1720 CTRPv2 pan-cancer AAC 0.14 0.0003
mRNA navitoclax:birinapant (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.13 0.0004
mRNA prima-1 CTRPv2 pan-cancer AAC 0.11 0.0008
mRNA SKI-II CTRPv2 pan-cancer AAC 0.12 0.001
mRNA MI-2 CTRPv2 pan-cancer AAC 0.18 0.001
mRNA ABT-199 CTRPv2 pan-cancer AAC 0.14 0.001
mRNA BRD-K27188169:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.17 0.001
mRNA sotrastaurin CTRPv2 pan-cancer AAC 0.12 0.002
Download CSV